Browse the full record of transactions filed by Spiegel Robert J., 董事. Director active across 4 companies, notably Cyclacel Pharmaceuticals, Inc.. Cumulatively, 32 filings have been logged. Breakdown: 1 buy · 0 sell. Activity tracked since 15 June 2021. The latest transaction was disclosed on 31 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Spiegel Robert J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Administrateur, Spiegel Robert J. has 32 filings in total. The 32 sampled filings, from 2021-06-17 to 2026-04-01, show Attribution transactions, all tied to GERON CORP, with total buy and sell amounts of 0.